439 related articles for article (PubMed ID: 33745729)
1. U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
Guidry JPD; Perrin PB; Laestadius LI; Vraga EK; Miller CA; Fuemmeler BF; Burton CW; Ryan M; Carlyle KE
Vaccine; 2021 Apr; 39(17):2452-2457. PubMed ID: 33745729
[TBL] [Abstract][Full Text] [Related]
2. Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries.
Roope LSJ; Barnett A; Candio P; Violato M; Duch R; Clarke PM
Appl Health Econ Health Policy; 2022 Jan; 20(1):55-65. PubMed ID: 34841474
[TBL] [Abstract][Full Text] [Related]
3. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
Hassan MA; Aliyu S
Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
[TBL] [Abstract][Full Text] [Related]
4. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
[No Abstract] [Full Text] [Related]
5. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
[TBL] [Abstract][Full Text] [Related]
6. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S
Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484
[TBL] [Abstract][Full Text] [Related]
7. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
Eccleston-Turner M; Upton H
Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
Sharun K; Dhama K
Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-incentivized blood donation: A survey of public perceptions in Canada.
Stoklosa K; Elfaki LA; Ding C; Sachal SS; Escuadro RJG; Tu K
Vox Sang; 2023 Aug; 118(8):624-636. PubMed ID: 37381906
[TBL] [Abstract][Full Text] [Related]
10. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
Hunter CM; Chou WS; Webb Hooper M
Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
[TBL] [Abstract][Full Text] [Related]
12. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
Enticott J; Gill JS; Bacon SL; Lavoie KL; Epstein DS; Dawadi S; Teede HJ; Boyle J;
BMJ Open; 2022 Jan; 12(1):e057127. PubMed ID: 34980631
[TBL] [Abstract][Full Text] [Related]
13. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
So AD; Woo J
BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
[TBL] [Abstract][Full Text] [Related]
14. Perceptions and knowledge regarding the COVID-19 pandemic between U.S. and China: a mixed methods study.
Xiong Y; Weng X; Snyder B; Ma L; Cong M; Miller EL; Van Scoy LJ; Lennon RP
Global Health; 2022 Aug; 18(1):76. PubMed ID: 35941625
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between the COVID-19 Pandemic and Vaccine Hesitancy: A Scoping Review of Literature Until August 2021.
de Albuquerque Veloso Machado M; Roberts B; Wong BLH; van Kessel R; Mossialos E
Front Public Health; 2021; 9():747787. PubMed ID: 34650953
[No Abstract] [Full Text] [Related]
16. Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.
Levin J; Bradshaw M
BMC Public Health; 2022 May; 22(1):1047. PubMed ID: 35614396
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities.
Govender K; Nyamaruze P; McKerrow N; Meyer-Weitz A; Cowden RG
BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35153193
[TBL] [Abstract][Full Text] [Related]
18. Multivalue ethical framework for fair global allocation of a COVID-19 vaccine.
Liu Y; Salwi S; Drolet BC
J Med Ethics; 2020 Aug; 46(8):499-501. PubMed ID: 32532826
[TBL] [Abstract][Full Text] [Related]
19. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
20. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.
Moodley K; Blockman M; Pienaar D; Hawkridge AJ; Meintjes J; Davies MA; London L
S Afr Med J; 2021 Mar; 111(6):554-558. PubMed ID: 34382565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
